Back to Case Studies

    Supercluster Project

    Scaling Up the Manufacturing Process for BrainPrint Bioink

    Healthcare

    Related Project Resources

    Project Dashboard

    PROJECT STATUS: ACTIVE

    • PROJECT BUDGET

      $406K

    • INDUSTRY INVESTMENT

      $126K

    • NGEN INVESTMENT

      $160K

    • OTHER INVESTMENT

      $32K

    Lead Company

    axolotl-biosciences

    Project Partners

    starfish
    axolotl-stephanie1

    "Axolotl Biosciences is pleased to be partnering with StarFish Medical to bring our cutting edge BrainPrint bioink to the rapidly growing biotechnology market. Our history of collaboration and their unique expertise in translating microfluidic technologies from benchtop to market makes them an ideal development partner."

    Dr. Stephanie Willerth

    CEO, Axolotl Biosciences

    Project Overview

    3D bioprinting enables the generation of human tissues on demand, which can serve as an important tool for screening potential drug targets. Axolotl Biosciences creates specialized bioinks that generate reproducible, functional human tissues derived from stem cells. Their newest bioink, BrainPrint, uses a patent pending microsphere drug delivery system to help create stable and mature human brain tissues from stem cells. 

    BrainPrint can be used with a variety of commercially available bioprinters to produce human neural tissues that replicate the chemical and electrical signals found in the brain. 

    StarFish Medical will focus on implementation of commercial scale microfluidic processes for fabricating the drug releasing microspheres based on prototypes developed in the Willerth and Elvira labs at the University of Victoria using the combined strengths of Axolotl Biosciences and StarFish Medical. 

    Axolotl Biosciences was selected as one of 25 winners and only Canadian company of the Falling Walls Venture 2022 competition.

    Have a Question?

    Should you have any any questions, comments, or concerns relating to this case study feel free to get in contact with us. We’d love to help.